Polymorphism of vascular endothelial growth factor 21154G>A (rs1570360) with cancer risk: A meta-analysis of 16 case-control studies

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5283-5289

  Hong, Ting Ting ^a   Zhang, Ru Xia ^a   Wu, Xiao Hong ^a   Hua, Dong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Cancer susceptibility; Meta analysis; VEGF polymorphism

Indexed keywords

ALANINE; GLYCINE; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; VASCULOTROPIN GENE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; PUBLISHING; RISK FACTOR;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863759169     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1326-9     Document Type: Article

References (25)

1. Shahbazi M, Fryer AA, Pravica V et al (2002) Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13:260-264
2. Pharoah PD, Tyrer J, Dunning AM et al (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3:e42
3. Jacobs EJ, Feigelson HS, Bain EB et al (2006) Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8:R22
4. Smith KC, Bateman AC, Fussell HM, Howell WM (2004) Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 31:167-173
5. Jin Q, Hemminki K, Enquist K et al (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647-3653
6. Dassoulas K, Gazouli M, Rizos S et al (2009) Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 48:563-569
7. Cacev T, Loncar B, Seiwerth S et al (2008) Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer. DNA Cell Biol 27:569-574
8. McCarron SL, Edwards S, Evans PR et al (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62:3369-3372
9. Sfar S, Saad H, Mosbah F, Chouchane L (2010) Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome. Hum Immunol 71:377-382
10. Jacobs EJ, Hsing AW, Bain EB et al (2008) Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev 17:972-977
11. Bruyere F, Hovens CM, Marson MN et al (2010) VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol 184:1273-1278
12. Ricketts C, Zeegers MP, Lubinski J, Maher ER (2009) Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. PLoS ONE 4:e6037
13. Li Y, Wang Y, Kang S et al (2010) Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer. Int J Gynecol Cancer 20:717-723
14. Tzanakis N, Gazouli M, Rallis G et al (2006) Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94:624-630
15. Howell WM, Bateman AC, Turner SJ et al (2002) Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 3:229-232
16. Garcia-Closas M, Malats N, Real FX et al (2007) Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms, bladder cancer risk. PLoS Genet 3:e29
17. Unal ZN, Unal M, Bagdatoglu OT et al (2008) Genetic polymorphism of VEGF -1154 (A/G) in laryngeal squamous cell carcinoma. Arch Med Res 39:209-211
18. Xu B, Li JM, Tong N et al (2010) VEGFA ?936C[T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet 198:7-14
19. Cao C, Fang JJ, Ying T et al (2010) Vascular endothelial growth factor ?936C/T and ?405G/C polymorphisms and cancer risk: a meta-analysis. Arch Med Res 41:548-557
20. Liu L, Liu L, Zeng F et al (2011) Meta-analysis of the association between VEGF -634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol 137:1027-1036
21. Cao C, Ying T, Fang JJ et al (2011) Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects. Med Oncol 28(4):1169-1175
22. Xu B, Feng NH, Tong N et al (2010) VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 27: 1031-1036
23. Koukourakis MI, Papazoglou D, Giatromanolaki A et al (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293-298
24. Kawai Y, Sakano S, Korenaga Y et al (2007) Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52:1147-1155
25. Schneider BP, Wang M, Radovich M et al (2008) Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol 26:4672-4678